InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: LifeLongLearner post# 161694

Monday, 04/26/2021 10:47:52 AM

Monday, April 26, 2021 10:47:52 AM

Post# of 233211

Even at the lower dosage the drug is clearly working.

The FDA is playing games with dosage in the cancer trial like they did in CD12 and HIV. The fact that the drug is achieving the results it is with the equivalent of one hand tied behind its back is a testament to the power of Leronlimab.


They want to up the dosage because results aren't optimal. That is obvious. CytoDyn always has excuses. Nothing is ever their fault.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News